We are live on
!
Find out more
GWM
GSB Wealth Management Portfolio holdings
AUM
$443M
1-Year Est. Return
17.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.92%
1 Year Est. Return
+17.59%
3 Year Est. Return
+45.9%
5 Year Est. Return
+57.79%
10 Year Est. Return
–
AUM
$387M
AUM Growth
-$3.63M
(-0.93%)
Cap. Flow
+$6.96M
Cap. Flow
% of AUM
1.8%
Top 10 Holdings %
Top 10 Hldgs %
26.27%
Holding
244
New
10
Increased
106
Reduced
87
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harbor International Compounders ETF
OSEA
|
+$2.44M |
| 2 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$1.41M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$1.29M |
| 4 |
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
|
+$1.29M |
| 5 |
Principal Spectrum Preferred Securities Active ETF
PREF
|
+$1.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.23M |
| 2 |
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
|
+$1.05M |
| 3 |
Dow Inc
DOW
|
+$1.03M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$1.02M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$902K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Industrials | 6.5% |
| 3 | Healthcare | 6.41% |
| 4 | Consumer Staples | 6.07% |
| 5 | Consumer Discretionary | 5.5% |
Similar funds
CP
CMP
BFA
AC
TC
HBT
EFMC
TAS
GSB Wealth Management's Q4 2024 Portfolio in Review
As of Q4 2024, GSB Wealth Management held 244 positions worth $387M, down 0.93% from $391M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
GSB Wealth Management's Q4 2024 filing shows 10 new, 106 increased, 87 reduced and 28 closed positions. Its largest new stake was Harbor International Compounders ETF: 89,320 shares worth $2.31M. The largest sale was Pfizer, an estimated $1.23M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Healthcare.
- GSB Wealth Management's largest Q4 2024 buy was Harbor International Compounders ETF: 89,320 shares worth $2.31M.
- GSB Wealth Management added most to Novo Nordisk in Q4 2024, an estimated $1.29M increase.
- GSB Wealth Management's biggest Q4 2024 reduction was Pfizer, cutting an estimated $1.23M.
- GSB Wealth Management fully exited CVS Health in Q4 2024, selling an estimated $563K.
- GSB Wealth Management's ten largest holdings make up 26% of its $387M portfolio in Q4 2024.
- GSB Wealth Management opened 10 new positions and closed 28 in Q4 2024.
- GSB Wealth Management's portfolio value fell 0.93% quarter-over-quarter to $387M.
Based on GSB Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.